Page 16 - Gastrointestinal Bleeding (Xuất huyết tiêu hóa)
P. 16

290     PART III  Symptoms, Signs, and Biopsychosocial Issues






















           A                                   B




                                                                                     Fig. 20.11  A, Epinephrine injection
                                                                                     and multipolar electrocoagulation
                                                                                     for hemostasis of a chronic gastric
                                                                                     ulcer (thick arrow) with a nonbleed-
                                                                                     ing visible vessel (thin arrow). B, The
                                                                                     nonbleeding visible vessel is injected
                                                                                     with epinephrine, after which blanching
                                                                                     and swelling of surrounding mucosa
                                                                                     occur. (Note that epinephrine injection
                                                                                     for a nonbleeding visible vessel is not
                                                                                     recommended in Table 20.6.) C, A
                                                                                     multipolar electrocoagulation probe
                                                                                     is applied with firm pressure and
                                                                                     coagulation. D, After completion of
           C                                   D                                     treatment, the visible vessel has been
                                                                                     coagulated and flattened.


















            A                                B                                C
                      Fig. 20.12  A, Gastric ulcer with a nonbleeding visible vessel (arrow) treated by endoscopy with epinephrine
                      injection (B) and hemoclip placement (C). (Note that epinephrine injection of a nonbleeding visible vessel is not
                      recommended in Table 20.6.)

         of a high-dose PPI. 135  With DEP guidance, underlying arterial   was  not  recommended;  however,  in  studies  with  DEP,  40%
         flow was detected in 46% of oozing ulcers, and hemostasis was   to  49%  of  ulcers  with  flat  spots  had  underlying  arterial  blood
         achieved with an MPEC probe or hemoclips; none had residual   flow. When those with a positive DEP for blood flow were not
         blood flow, and after treatment with oral PPIs twice daily, none   treated endoscopically and managed medically, half rebled. 111
         rebled. 106  Oozing ulcers should be considered to have an inter-  Similar to oozing bleeding (Forrest 1A), we now classify patients
         mediate risk of rebleeding. 106,107,111,112,135      with  flat  spots  (Forrest  IIC)  as  having  an  intermediate  risk  of
                                                              rebleeding. 106,111,135  Epinephrine injection alone only transiently
         Flat Spots                                           reduced arterial blood flow. When DEP is positive, either MPEC
         In the past, patients with flat spots in ulcers (Forrest IIC) were   or hemoclips are recommended to obliterate underlying arterial
         considered at low risk for rebleeding, and endoscopic hemostasis   blood flow and to prevent rebleeding. 111  
   11   12   13   14   15   16   17   18   19   20   21